Gadopiclenol in Contrast Enhanced MRI of the Prostate — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Gadopiclenol in Contrast Enhanced MRI of the Prostate — Stella

Home/Prostate Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Prostate Cancer trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Columbia University Medical Center, New York, New York

Key details

Phase

Post-approval study

Sponsor

Columbia University

Collaborators

Guerbet

Enrollment target

~150 participants

Started

February 2024

Primary completion

February 2027

Age range

18 Years and older

Sex

Male only

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.